Delivery Order SPE2DB24D2100-SPE2DB24FBDUH

Award Date 9/28/24
Potential Completion Date 9/30/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a delivery order worth $2,875.50 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,837,064 units of Epinephrine 0.3 mg auto-injectors. This delivery order is a part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which provides a comprehensive range of medical commodities to support military treatment programs and facilities...
The Defense Logistics Agency (DLA) awarded a $1,550.76 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,749,613 units of epinephrine 0.3 mg auto-injector 2-packs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to supply a comprehensive range of medical commodities to support military treatment programs...
The U.S. Defense Logistics Agency (DLA) awarded a $8,497.78 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,764,629 units of Epinephrine 0.3 mg auto-injectors. This is a child contract under AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive vehicle for supplying a range of pharmaceutical products and medical supplies to support...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide epinephrine 0.3 mg auto-injectors. The $1,710.38 contract has a completion date of December 5, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,209.24 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of EPINEPHRINE 0.3 MG AUTO-INJECT 2S. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
The Defense Logistics Agency (DLA) awarded a $16,563.32 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation for the supply of 4,565,661,114 units of Epinephrine 0.3 mg Auto-Injectors. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. AmerisourceBergen, a...
The U.S. Defense Logistics Agency (DLA) awarded a $7,279.85 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,735,813 units of EPINEPHRINE 0.3 MG AUTO-INJECT 2S. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of medical commodities to support military treatment programs and...
The U.S. Defense Logistics Agency (DLA) awarded a $1,373.67 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,556,974,597 units of Epinephrine 0.3 mg auto-injectors. This contract has an ultimate completion date of April 25, 2022 and was not designated with a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a $4,377.38 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,617,803 units of Epinephrine 0.3 mg auto-injectors. The order has an ultimate completion date of August 29, 2024 and was awarded on August 28, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the DLA to efficiently...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,833.96 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of 4,564,097,693 units of epinephrine 0.3 mg auto-injectors. This delivery order falls under a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31,...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB24FBDUH
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $14,417.18 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of 4,565,970.743 units of Epinephrine 0.3 mg auto-injectors. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This contract award does not have a set-aside designation and is scheduled for completion by September 30, 2024.

Generated 12/28/24, 9:03 AM